# A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)

Study · id `cardio:ct-nct01307033` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01307033](<https://clinicaltrials.gov/study/NCT01307033>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01307033

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 278 participants.

## Technical summary

Registry record NCT01307033. Randomized; double masking; primary purpose treatment. Start 2011-03-29 (actual); primary completion 2012-12-04 (actual). Results posted on 2014-01-06.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 278 participants (enrolled count; ClinicalTrials.gov record NCT01307033, source copy `cardio:ctgov-nct01307033-2024-05-17`, retrieved 2026-10-26)
- Started: 2011-03-29 (actual) (ClinicalTrials.gov record NCT01307033, source copy `cardio:ctgov-nct01307033-2024-05-17`, retrieved 2026-10-26)
- Primary completion: 2012-12-04 (actual) (ClinicalTrials.gov record NCT01307033, source copy `cardio:ctgov-nct01307033-2024-05-17`, retrieved 2026-10-26)
- Completion: 2012-12-04 (actual) (ClinicalTrials.gov record NCT01307033, source copy `cardio:ctgov-nct01307033-2024-05-17`, retrieved 2026-10-26)
- Results first posted: 2014-01-06 (ClinicalTrials.gov record NCT01307033, source copy `cardio:ctgov-nct01307033-2024-05-17`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01307033-2024-05-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
- Condition: Hypertension
- Intervention (Drug): MK-0954A
- Intervention (Drug): MK-954H
- Intervention (Drug): Placebo to MK-0954A
- Intervention (Drug): Placebo to MK-954H
- Lead sponsor: Organon and Co
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Organon and Co (`cardio:org-organon-and-co`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials (`cardio:pubmed-24990091`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 38139f08ca135876eb2ebfc7a9f3aa50d2e47b80d9d82a9586653069548da3c0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
